Usage: Aripiprazole Oral Tablets are indicated for the treatment of schizophrenia, irritability associated with autistic disorder, and Tourette’s disorder.
Usage: Aripiprazole Oral Solution is indicated for the treatment of schizophrenia, acute manic and mixed episodes of Bipolar I Disorder, adjunctive treatment of major depressive disorder, irritability associated with autistic disorder, and Tourette’s disorder.
Usage: Aripiprazole Oral Tablets are indicated for treating schizophrenia, acute manic and mixed episodes of Bipolar I Disorder, as an adjunctive treatment for Major Depressive Disorder, irritability associated with autistic disorder, and Tourette’s disorder.
Usage: Aripiprazole tablets are indicated for the treatment of schizophrenia, acute manic and mixed episodes in bipolar I disorder, adjunctive treatment of major depressive disorder, irritability associated with autistic disorder, and Tourette's disorder.
Usage: Aripiprazole orally disintegrating tablets are indicated for treating schizophrenia, irritability associated with autistic disorder, and Tourette's disorder.
Usage: RISPERDAL (risperidone) is indicated for the treatment of schizophrenia, acute manic or mixed episodes of Bipolar I Disorder (as monotherapy or adjunctive therapy), and irritability associated with autistic disorder in children and adolescents. Efficacy is supported by multiple clinical trials in various age groups.
Usage: Risperidone tablets are indicated for the treatment of schizophrenia, acute manic or mixed episodes of Bipolar I Disorder (as monotherapy or adjunctive therapy), and irritability associated with autistic disorder in children and adolescents. Efficacy is supported by multiple short-term clinical trials.